Page 248 - Read Online

Dobric et al. Vessel Plus 2019;3:26 I http://dx.doi.org/10.20517/2574-1209.2018.77 Page 7 of 7

24. Mashayekhi K, Nührenberg TG, Toma A, Gick M, Ferenc M, et al. A Randomized Trial to Assess Regional Left Ventricular Function
After Stent Implantation in Chronic Total Occlusion: The REVASC Trial. JACC Cardiovasc Interv 2018;11:1982-91.
25. Werner GS, Martin-Yuste V, Hildick-Smith D, Boudou N, Sianos G, et al. A randomized multicentre trial to compare revascularization
with optimal medical therapy for the treatment of chronic total coronary occlusions. Eur Heart J 2018;39:2484-93.
26. Lee SW, Lee PH, Ahn JM, Park DW, Yun SC, et al. Randomized Trial Evaluating Percutaneous Coronary Intervention for the Treatment
of Chronic Total Occlusion. Circulation 2019;139:1674-83.
27. Boden WE, O’Rourke RA, Teo KK, Hartigan PM, Maron DJ, et al. Optimal medical therapy with or without PCI for stable coronary
disease. N Engl J Med 2007;356:1503-16.
28. Al-Lamee R, Thompson D, Dehbi HM, Sen S, Tang K, et al. Percutaneous coronary intervention in stable angina (ORBITA): A double-
blind, randomised controlled trial. Lancet 2017;6736:1-11.
29. Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization.
Eur Heart J 2018;1-96.
30. Authors/Task Force members, Windecker S, Kolh P, Alfonso F, Collet J-P, Cremer J, et al. 2014 ESC/EACTS Guidelines on myocardial
revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European
Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous
Cardiovascular Interventions (EAPCI). Eur Heart J 2014;35:2541-619.
31. Arain SA, Anderson HV. The SYNTAX Score for Chronic Total Occlusions: Building a Better Mousetrap. J Invasive Cardiol
2017;29:132-3.